Hoffman Mitchel S
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of South Florida, Tampa, FL 33606, USA.
Best Pract Res Clin Obstet Gynaecol. 2003 Aug;17(4):635-47. doi: 10.1016/s1521-6934(03)00051-8.
About 30-40% of vulvar cancers present with International Federation of Gynecology and Obstetrics (FIGO) (clinical) stage III or IV disease. Although surgical staging was introduced by FIGO in 1988 and hard data on this system are still relatively few, a review of our own patients suggests that this percentage of patients with advanced stage vulvar cancer probably still holds. We have considered carcinoma of the vulva to be locally advanced when the primary or recurring tumour cannot be locally managed by a radical vulvar resection. Current approaches to the treatment of locally advanced vulvar cancer include ultraradical surgery, radiotherapy, chemo-radiotherapy and a combination of treatment modalities. This chapter reviews the current approaches to the treatment of locally advanced vulvar cancer.
约30%-40%的外阴癌患者就诊时为国际妇产科联盟(FIGO)(临床)III期或IV期疾病。尽管FIGO于1988年引入了手术分期,且关于该系统的确切数据仍然相对较少,但对我们自己患者的回顾表明,晚期外阴癌患者的这一比例可能仍然保持不变。当原发性或复发性肿瘤无法通过根治性外阴切除术进行局部处理时,我们认为外阴癌为局部晚期。目前治疗局部晚期外阴癌的方法包括超根治性手术、放疗、放化疗以及多种治疗方式的联合应用。本章回顾了目前治疗局部晚期外阴癌的方法。